Evidence map›Paper›PMID 38067627›Full record

ReviewMolecules (Basel, Switzerland)2023

Progress in Catalytic Asymmetric Reactions with 7-Azaindoline as the Directing Group.

Yan-Ping Zhang, Yong You, Jun-Qing Yin, Zhen-Hua Wang, Jian-Qiang Zhao, Wei-Cheng Yuan

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yan-Ping ZhangSchool of Pharmacy, Chengdu University, Chengdu 610106, China.
Yong YouInstitute of Advanced Study, Chengdu University, Chengdu 610106, China.
Jun-Qing YinInstitute of Advanced Study, Chengdu University, Chengdu 610106, China.
Zhen-Hua WangInstitute of Advanced Study, Chengdu University, Chengdu 610106, China.ORCID 0000-0002-0603-707X
Jian-Qiang ZhaoInstitute of Advanced Study, Chengdu University, Chengdu 610106, China.ORCID 0000-0002-4444-9630
Wei-Cheng YuanInstitute of Advanced Study, Chengdu University, Chengdu 610106, China.
Chengdu University · CN

Funding

National Natural Science Foundation of China 22171029National Natural Science Foundation of China 22271027National Natural Science Foundation of China 22302021Natural Science Foundation of Sichuan Province 2023NSFSC1080Talent Program of Chengdu University 2081919035Talent Program of Chengdu University 2081921038Talent Program of Chengdu University 2081923010
6 · The paper itself

Abstract

α-Substituted-7-azaindoline amides and α,β-unsaturated 7-azaindoline amides have emerged as new versatile synthons for various metal-catalyzed and organic-catalyzed asymmetric reactions, which have attracted much attention from chemists. In this review, the progress of research on 7-azaindoline amides in the asymmetric aldol reaction, the Mannich reaction, the conjugate addition, the 1,3-dipole cycloaddition, the Michael/aldol cascade reaction, aminomethylation and the Michael addition-initiated ring-closure reaction is discussed. The α-substituted-7-azaindoline amides, as nucleophiles, are classified according to the type of α-substituted group, whereas the α,β-unsaturated 7-azaindoline amides, as electrophiles, are classified according to the type of reaction.

Indexed as

7-azaindoline amidesasymmetric synthesisdirecting groupenolization chemistrymetal catalysisorganocatalysis

Identifiers

PMID38067627
PMCPMC10707968
OpenAlexW4389246596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.